Table 2.
Study author | Diseases | Who distributed the drugs | Who managed the programme | Outcome |
Lemos et al28 | Schistosomiasis STH Malaria Anaemia |
Centro de Investigação em Saúde de Angola lab workers | Government and researchers | All anaemia cases were associated with schistosomiasis −13.5% reduction in schistosomiasis infections with no significant changes in anaemia |
Lemoine et al51 | LF STH |
Community drug distributors, | ENVISION project | 100% coverage from as low as 30% |
Njenga et al29 | Hookworm (STH) Urogenital Schistosomiasis |
Trained schoolteachers | Authors | Did not change both the overall prevalence and intensity of hookworm infection. |
Ndayishimiye et al35 | STH Schistosomiasis Onchocerciasis Trachoma |
Community drug distributors and community health workers | Ministry of Health | Increase in total population covered from 3 209 521 in 2007 to 4 179 495 in 2010 |
Leslie et al65 | STH Schistosomiasis LF Trachoma |
– | Government | Integrated programme cost 21% less than vertical programmes |
Evans et al30 | STH Schistosomiasis Onchocerciasis LF |
Community drug distributors | Ministry of Health | 98%–100% coverage, reduction in cost by 41.1% |
Mwinzi et al50 | STH Schistosomiasis |
Community drug distributors | Ministry of Health | 52.3% to 91.9% coverage with a 69% prevalence reduction for hookworm |
Mani et al67 | STH LF |
Community health workers | – | 77% prevalence reduction compared 15% reduction for single drug (3× increase in control) |
Bronzan et al27 | STH Schistosomiasis |
– | Ministry of Health | Decrease in STH prevalence from 31.1% in 2009 to 11% in 2015 -Schisto 23.5% to 5% |
‘-’ means not clear.
LF, lymphatic filariasis; STH, soil transmitted helminths.